Back to search
FDAFDA · Food and drugs·Recall number D-0773-2016

NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL

Published March 23, 2016 · Recall initiated: November 19, 2015

Summary

FDA records drug Class III recall D-0773-2016, published March 23, 2016 and initiated November 19, 2015. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 576 bottles; Lot: Lot #: 05N533, Exp 11/16. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide and Puerto Rico.
Lot
Lot #: 05N533, Exp 11/16
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NABUMETONE Tablets USP, 750 mg, 100 count bottle,Teva Pharmaceutical Industries Ltd., Jerusalem, 91010, ISRAEL recalled?

Yes. FDA published recall D-0773-2016 on March 23, 2016. Reported hazard: Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter